Unbiased Analysis of Today's Healthcare Issues
LLM approach expert levels in ophthalmology. Price controls in health care (Argentina) Will bird flu (H5N1) animal pandemic spread to humans? Lex Fridman interview with Mark Cuban (with discussion of Cost Plus Drugs) Spotlight on Medicare’s Chronic Care Management program.
Some key trends to watch from some of my colleagues at FTI in their article The Evolution of Healthcare: Trends to Watch in 2024. Commercialization of Healthcare. Over the past decade, private equity’s presence in the healthcare sector has significantly accelerated, with annual deal values soaring from $41.5 billion in 2010 to $119.9 billion in…
I will be speaking on two panels at the upcoming ISPOR 2024 conference in Atlanta, GA. Myfirst panel “Economic Insights Into Nutrition: Unlocking the Value in Chronic Disease Management” on Tuesday, May 7, will discuss the opportunities and challenges of economic evaluation of nutrition interventions and compare economic analysis of nutrition interventions with analysis of…
Generative AI for economists. Juvenile curfews on teenage birth rates. Cato on Biden Short‐Term Health Plans Rule. Parents’ education on children’s earnings. DTx for MDD.
People won’t be surprised to learn that AI could improve the accuracy of diagnosis, expedite the rates of drug discovery, or even replace some (or many) activities typically done by doctors. However, can AI save the health care system money? That is the question asked by a recent article in The Economist titled “Can artificial…
HEOR and decentralized clinical trials. State to crack down on prior authorizations? Memory formation and DNA. AI eye exams. Lessons on learning: Jason Kelce on band.
FDA on AI. Rural hospital closures on maternal and infant health. Price caps for obesity drugs? One framework for fair drug pricing. Iterative approach to model-based decision making in health.
The future of economics. Hacker attack on health data. Where is air pollution highest in low- and middle-income countries. 5.8m children have long COVID Underrated: the HPV vaccine.
Perhaps so according to the health policy editor at the Guardian. He writes that as NHS has grown weaker, private medical insurance is becoming a more attractive option. The long delays for NHS care that are now endemic – and cause so much worry, risk and harm to those left waiting – are not going…
How NICE has applied it’s disease severity modifier. Non-profit hospitals and bond ratings. Calculating cell & gene therapy breakeven point using RWD. Public vs. private Medicaid. Supplementing VA with private insurance.